RS3903703 Unknown gene

Other Chr ?:?
Upload your DNA to see your genotype for this variant.
GWAS Studies (18)
Trait Risk Allele OR / Beta P-value Study
Sphingomyelin(43:2)_[M-CH3]1- levels G β: 0.071 9E-12 PubMed
Ceramide(40:2)_[M-H]1- levels G β: 0.056 9E-12 PubMed
Ceramide(40:1)_[M-H]1- levels A β: 0.04 9E-12 PubMed
Ceramide(40:0)_[M-H]1- levels G β: 0.078 9E-12 PubMed
Ceramide(41:2)_[M-H]1- levels G β: 0.056 9E-12 PubMed
Ceramide(41:1)_[M-H]1- levels T β: 0.095 9E-12 PubMed
Ceramide(41:0)_[M-H]1- levels G β: 0.085 9E-12 PubMed
Ceramide(42:0)_[M-H]1- levels C β: 0.077 9E-12 PubMed
Sphingomyelin(32:1)_[M+H]1+ levels G β: 0.061 9E-12 PubMed
Sphingomyelin(37:1)_[M-CH3]1- levels T β: 0.078 9E-12 PubMed
Sphingomyelin(37:1)_[M+H]1+ levels C β: 0.046 9E-12 PubMed
Sphingomyelin(39:1)_[M-CH3]1- levels A OR: 0.18 9E-12 PubMed
Sphingomyelin(38:1)_[M+H]1+ levels T β: 0.078 9E-12 PubMed
Sphingomyelin(39:1)_[M+H]1+ levels G β: 0.075 9E-12 PubMed
Phosphatidylcholine-O(36:1)_[M+H]1+/Phosphatidylethanolamine-O(39:1)_[M+H]1+/Phosphatidylcholine-P(36:0)_[M+H]1+ levels G β: 0.056 9E-12 PubMed
Ceramide (d18:2/18:0) levels G OR: 0.13 1E-8 PubMed
Very long-chain saturated fatty acid levels (fatty acid 24:0) A OR: 4.52 6E-6 PubMed
Sphingomyelin (d18:0/20:0, d16:0/22:0) levels in elite athletes OR: 0.31 7E-6 PubMed
Ask Dr. Hemsworth about this variant